Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Turmacin
- Development stage
- Unknown
- Lead developer
- Natural Remedies
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
NR-INF-02 (Turmacin) is a standardized, water-soluble extract of *Curcuma longa* (turmeric) developed by Natural Remedies. Unlike traditional turmeric extracts that focus on curcuminoids, NR-INF-02 is enriched with turmerosaccharides. It is primarily investigated for its anti-inflammatory and analgesic properties in the treatment of joint disorders, specifically knee osteoarthritis. Clinical studies have demonstrated its efficacy in reducing pain (measured by Visual Analog Scale, VAS) and improving joint function (measured by Western Ontario and McMaster Universities Osteoarthritis Index, WOMAC) with a safety profile comparable to placebo. The extract is marketed as a nutraceutical ingredient for joint health and mobility.
- Brand names
- Turmacin
- Other names
- Curcuma longa extractturmeric extractturmerosaccharides
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Turmacin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Turmacin.